1026 related articles for article (PubMed ID: 16055622)
1. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Soler-Cataluña JJ; Martínez-García MA; Román Sánchez P; Salcedo E; Navarro M; Ochando R
Thorax; 2005 Nov; 60(11):925-31. PubMed ID: 16055622
[TBL] [Abstract][Full Text] [Related]
2. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.
Short PM; Lipworth SI; Elder DH; Schembri S; Lipworth BJ
BMJ; 2011 May; 342():d2549. PubMed ID: 21558357
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia and its clinical correlation in elderly chronic obstructive pulmonary disease: a prospective cohort study.
Wu JF; Jia J; Chen P; Wang XF; Yang FX; Liu Y; Ma YM; Jin JW
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9762-9772. PubMed ID: 37916340
[TBL] [Abstract][Full Text] [Related]
4. Black Carbon Content in Airway Macrophages is Associated with Reduced CD80 Expression and Increased Exacerbations in Former Smokers With COPD.
Tejwani V; Moughames E; Suresh K; Tang SE; Mair LG; Romero K; Putcha N; Alexis NE; Woo H; D'Alessio FR; Hansel NN
Chronic Obstr Pulm Dis; 2021 Jan; 8(1):91-9. PubMed ID: 33156984
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to exacerbation in chronic obstructive pulmonary disease.
Hurst JR; Vestbo J; Anzueto A; Locantore N; Müllerova H; Tal-Singer R; Miller B; Lomas DA; Agusti A; Macnee W; Calverley P; Rennard S; Wouters EF; Wedzicha JA;
N Engl J Med; 2010 Sep; 363(12):1128-38. PubMed ID: 20843247
[TBL] [Abstract][Full Text] [Related]
6. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Paul EA; Bestall JC; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1418-22. PubMed ID: 9603117
[TBL] [Abstract][Full Text] [Related]
7. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality.
Suissa S; Dell'Aniello S; Ernst P
Thorax; 2012 Nov; 67(11):957-63. PubMed ID: 22684094
[TBL] [Abstract][Full Text] [Related]
8. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Vestbo J; Hurd SS; Agustí AG; Jones PW; Vogelmeier C; Anzueto A; Barnes PJ; Fabbri LM; Martinez FJ; Nishimura M; Stockley RA; Sin DD; Rodriguez-Roisin R
Am J Respir Crit Care Med; 2013 Feb; 187(4):347-65. PubMed ID: 22878278
[TBL] [Abstract][Full Text] [Related]
9. COPD exacerbations: defining their cause and prevention.
Wedzicha JA; Seemungal TA
Lancet; 2007 Sep; 370(9589):786-96. PubMed ID: 17765528
[TBL] [Abstract][Full Text] [Related]
10. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
Calverley PM; Anderson JA; Celli B; Ferguson GT; Jenkins C; Jones PW; Yates JC; Vestbo J;
N Engl J Med; 2007 Feb; 356(8):775-89. PubMed ID: 17314337
[TBL] [Abstract][Full Text] [Related]
11. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments).
Connors AF; Dawson NV; Thomas C; Harrell FE; Desbiens N; Fulkerson WJ; Kussin P; Bellamy P; Goldman L; Knaus WA
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):959-67. PubMed ID: 8887592
[TBL] [Abstract][Full Text] [Related]
12. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
13. Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
Wedzicha JA; Banerji D; Chapman KR; Vestbo J; Roche N; Ayers RT; Thach C; Fogel R; Patalano F; Vogelmeier CF;
N Engl J Med; 2016 Jun; 374(23):2222-34. PubMed ID: 27181606
[TBL] [Abstract][Full Text] [Related]
14. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.
Wedzicha JA; Calverley PM; Seemungal TA; Hagan G; Ansari Z; Stockley RA;
Am J Respir Crit Care Med; 2008 Jan; 177(1):19-26. PubMed ID: 17916806
[TBL] [Abstract][Full Text] [Related]
15. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study.
Wedzicha JA; Decramer M; Ficker JH; Niewoehner DE; Sandström T; Taylor AF; D'Andrea P; Arrasate C; Chen H; Banerji D
Lancet Respir Med; 2013 May; 1(3):199-209. PubMed ID: 24429126
[TBL] [Abstract][Full Text] [Related]
16. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
Watz H; Tetzlaff K; Wouters EF; Kirsten A; Magnussen H; Rodriguez-Roisin R; Vogelmeier C; Fabbri LM; Chanez P; Dahl R; Disse B; Finnigan H; Calverley PM
Lancet Respir Med; 2016 May; 4(5):390-8. PubMed ID: 27066739
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Anthonisen NR; Manfreda J; Warren CP; Hershfield ES; Harding GK; Nelson NA
Ann Intern Med; 1987 Feb; 106(2):196-204. PubMed ID: 3492164
[TBL] [Abstract][Full Text] [Related]
18. Changes in forced expiratory volume in 1 second over time in COPD.
Vestbo J; Edwards LD; Scanlon PD; Yates JC; Agusti A; Bakke P; Calverley PM; Celli B; Coxson HO; Crim C; Lomas DA; MacNee W; Miller BE; Silverman EK; Tal-Singer R; Wouters E; Rennard SI;
N Engl J Med; 2011 Sep; 365(13):1184-92. PubMed ID: 21991892
[TBL] [Abstract][Full Text] [Related]
19. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
Bafadhel M; McKenna S; Terry S; Mistry V; Reid C; Haldar P; McCormick M; Haldar K; Kebadze T; Duvoix A; Lindblad K; Patel H; Rugman P; Dodson P; Jenkins M; Saunders M; Newbold P; Green RH; Venge P; Lomas DA; Barer MR; Johnston SL; Pavord ID; Brightling CE
Am J Respir Crit Care Med; 2011 Sep; 184(6):662-71. PubMed ID: 21680942
[TBL] [Abstract][Full Text] [Related]
20. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort.
Müllerova H; Maselli DJ; Locantore N; Vestbo J; Hurst JR; Wedzicha JA; Bakke P; Agusti A; Anzueto A
Chest; 2015 Apr; 147(4):999-1007. PubMed ID: 25356881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
